4933402E13Rik Activators

Trichostatin A is a histone deacetylase inhibitor that can lead to the hyperacetylation of histones, causing a relaxed chromatin structure and increased gene expression. This can enhance the transcription of various genes, including those involved in cellular stress responses. The activation of stress response elements by Trichostatin A can result in the increased activity of MAGE family member C2, as the protein is known to be involved in stress-related cellular pathways.

5-Azacytidine, a DNA methyltransferase inhibitor, causes hypomethylation of DNA. Hypomethylation can lead to the activation of silenced genes, which may include genes that code for proteins interacting with MAGE family member C2. By activating these interacting proteins, which are part of the pathways MAGE family member C2 is involved in, 5-Azacytidine can increase the functional activity of MAGE family member C2.

MG132 is a proteasome inhibitor that prevents the degradation of ubiquitin-tagged proteins. By inhibiting the proteasome, MG132 can increase the levels of proteins that regulate the ubiquitin-proteasome system, a pathway where MAGE family member C2 is known to be involved. The increased levels of these regulatory proteins can enhance the activity of MAGE family member C2 by stabilizing it and preventing its degradation.

Similar to MG132, Epoxomicin is a selective proteasome inhibitor that leads to the accumulation of proteins involved in the ubiquitin-proteasome pathway. The build-up of these regulatory proteins can result in the activation of MAGE family member C2, as it functions within this pathway, potentially by stabilizing the protein and enhancing its interactions with other pathway components.

Withaferin A is known to inhibit the proteasomal activity and has been shown to induce oxidative stress within cells. Oxidative stress can activate stress response pathways, which are connected to the activity of MAGE family member C2. Through this mechanism, Withaferin A can enhance the functional activity of MAGE family member C2 as part of the cellular stress response.

Disulfiram can chelate copper and form a complex that inhibits the proteasome. This inhibition can lead to the activation of pathways involved in protein turnover and stress response, which include proteins that interact with MAGE family member C2. By stabilizing these interacting proteins, Disulfiram can indirectly activate MAGE family member C2.

Bortezomib, a well-known proteasome inhibitor, can lead to the accumulation of proteins within the ubiquitin-proteasome pathway. This accumulation can cause a stress response that activates MAGE family member C2, given its role in stress-related signaling.

Lactacystin is a proteasome inhibitor that can cause the accumulation of proteins that are normally targeted for degradation. The accumulation of such proteins can activate MAGE family member C2 by stabilizing it and promoting its function in the ubiquitin-proteasome pathway.

Betulinic acid induces oxidative stress in cells, which can activate stress response pathways. MAGE family member C2 is involved in these pathways, and the activation of these pathways can lead to the functional activation of MAGE family member C2.

Geldanamycin binds to heat shock protein 90 (Hsp90) and inhibits its function. By inhibiting Hsp90, Geldanamycin can disrupt the degradation of client proteins, leading to the activation of stress responses that engage MAGE family member C2, thereby increasing its activity.